Instrument Inactif

Autres langues Viralytics Ltd. Other OTC

Actions

Recherche biotechnologique et médicale

Autres langues

21/02/18	Amgen : Merck to buy virus-based cancer drug firm Viralytics for $394 million
28/11/17	Viralytics : Chairman’s letter to shareholders
12/11/17	Viralytics : New Data Presented at SITC Annual Meeting
18/08/17	Viralytics : Annual Report and Full Year Financial Results
28/06/17	Viralytics : Newsletter
28/06/17	Viralytics : Positive Bio-Marker Data from CANON Study
06/06/17	Viralytics : Update on MITCI and KEYNOTE 200 trials at ASCO Ann Meeting
05/04/17	Viralytics : Progress in the CAVATAK® and KEYTRUDA® Combination KEYNOTE-200 clinical trial
05/04/17	Viralytics : CAVATAK® in Combination with YERVOY® Provides Promising Results in Advanced Melanoma from the Phase 1b MITCI clinical study
04/04/17	Viralytics : Promising Results in CAPRA Trial of CAVATAK® in Combination with KEYTRUDA® in Melanoma Patients
09/03/17	Viralytics : Edison Report – Cavatak combo data at AACR next month
02/03/17	Viralytics : ASX Release – Viralytics to Present New CAVATAK Clinical Data at American Association for Cancer Research Annual Meeting 2017
16/02/17	Viralytics : Receives $4.3 Million R&D Tax Incentive
14/11/16	Viralytics : Promising Advanced Melanoma Results from KEYTRUDA Combination Trial announced at SITC
06/06/16	Viralytics : Dr Malcolm McColl on ABC TV's The Business
10/05/16	Edison: Eye-catching MITCI Data
21/04/16	Viralytics : Further Promising Data at AACR Meeting
17/03/16	Viralytics : Clinical Results at Two Major Conferences
21/12/15	Viralytics : Bioshares Top Six Stock Picks for 2016
16/12/15	Viralytics : Completes $28 million Placement – SPP to Followm
30/06/15	Viralytics : on ABC TV ''The Business''
18/06/15	Viralytics : ROTH Capital Partners - Updated Research Note
10/06/15	Viralytics : to Present Initial Bladder Cancer Results at Oncolytic Virus Conference
02/06/15	Viralytics : Positive final results from CAVATAK Phase 2 Melanoma Trial
06/05/15	Viralytics : FDA Advisory Vote on Amgen’s T-Vec a Positive for Viralytics